The Committee concluded, having taking into account to all of the reasons considered above 
that choice could not be given enough weight and that there was not at this time a gap
 on the spectrum of fairly sufficient to conclude that the rules of pharmaceutical 
services is not at this time fixed to the standard of fairness. 